Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381717 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Femoral Nerve Block
A NA study of Hip Fracture, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT02381717: Completed NA study of Hip Fracture, sponsored by Beth Israel Deaconess Medical Center.
NCT02381717 is a NA study of Hip Fracture that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 44 participants, below the 107-participant average among 5 other Hip Fracture trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02381717, a NA study of Hip Fracture, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.
Primary Outcome
Evaluation of pain severity and relief will be assessed utilizing a Visual Analog Scale (VAS)
Conditions Studied
Interventions
- DRUG bupivacaine
- DRUG morphine
- OTHER ultra-sound guide
Study Locations (2)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- St. Vincent's Hospital - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-08 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the finished NCT02381717 record still lists
NCT02381717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 107-participant average among 5 other Hip Fracture trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Hip Fracture appearing as the primary indexed condition, and to 3 interventions - of which bupivacaine is the first listed.
NCT02381717 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02381717 about?
NCT02381717 is a clinical study titled "Ultrasound Guided Femoral Nerve Block". The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture...
What is the current status of trial NCT02381717?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-08. Estimated completion is 2025-12.
What conditions does trial NCT02381717 study?
This clinical trial studies the following conditions: Hip Fracture.
What interventions are being tested in trial NCT02381717?
The interventions under investigation include: bupivacaine (DRUG), morphine (DRUG), ultra-sound guide (OTHER).
Who is sponsoring clinical trial NCT02381717?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02381717 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PENG vs. FIC Block for Hip Fracture ED Patients
ACTIVE NOT RECRUITING · NA
-
BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women
COMPLETED · NA
-
Efficacy of a Post-Rehabilitation Exercise Intervention
COMPLETED · NA
-
Testosterone Therapy After Hip Fracture in Elderly Women
COMPLETED · Phase 2
-
Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia